Simulations Plus, Inc. (NASDAQ:SLP) Shares Bought by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC grew its holdings in Simulations Plus, Inc. (NASDAQ:SLP) by 18.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 85,275 shares of the technology company’s stock after buying an additional 13,418 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Simulations Plus were worth $2,731,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Royce & Associates LP grew its stake in Simulations Plus by 28.8% during the 3rd quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after acquiring an additional 53,092 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of Simulations Plus by 2.6% in the third quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company’s stock valued at $2,794,000 after purchasing an additional 2,226 shares during the last quarter. US Bancorp DE lifted its position in Simulations Plus by 37.0% during the third quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock worth $159,000 after buying an additional 1,343 shares in the last quarter. Congress Asset Management Co. boosted its stake in Simulations Plus by 22.5% during the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock worth $6,613,000 after buying an additional 37,914 shares during the last quarter. Finally, Semanteon Capital Management LP purchased a new stake in Simulations Plus in the 3rd quarter valued at $358,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

Simulations Plus Stock Performance

NASDAQ:SLP opened at $31.32 on Friday. Simulations Plus, Inc. has a fifty-two week low of $27.07 and a fifty-two week high of $51.22. The company has a 50 day moving average price of $30.80 and a 200 day moving average price of $38.31. The stock has a market capitalization of $628.59 million, a P/E ratio of 63.92 and a beta of 0.71.

Simulations Plus (NASDAQ:SLP) last released its quarterly earnings results on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.02. The business had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company’s quarterly revenue was up 19.9% on a year-over-year basis. During the same period last year, the business posted $0.18 earnings per share. Research analysts forecast that Simulations Plus, Inc. will post 1.12 earnings per share for the current fiscal year.

Insider Buying and Selling at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $35.18, for a total value of $703,600.00. Following the completion of the transaction, the director now owns 3,501,592 shares in the company, valued at approximately $123,186,006.56. The trade was a 0.57 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold a total of 60,750 shares of company stock valued at $1,905,655 in the last three months. 20.90% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on SLP shares. Stephens started coverage on Simulations Plus in a report on Friday, November 15th. They set an “overweight” rating and a $39.00 price target on the stock. BTIG Research reduced their target price on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research note on Thursday, October 24th. StockNews.com cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. KeyCorp initiated coverage on shares of Simulations Plus in a research report on Monday, July 29th. They set an “overweight” rating and a $47.00 price target on the stock. Finally, William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Simulations Plus currently has a consensus rating of “Moderate Buy” and a consensus target price of $51.40.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.